| HOME >> MEDICINE >> TECHNOLOGY |
Figure 5.3 McKesson Pharmaceutical Gross Profit Margin (%), 2009-2011
Figure 5.4 McKesson Revenue Forecast ($bn), 2011-2022
Figure 5.5 Cardinal Health Revenue (%) by Company, 2011
Figure 5.6 Cardinal Health Revenue Forecast ($bn), 2011-2022
Figure 5.7 AmerisourceBergen Revenue Forecast ($bn), 2011-2022
Figure 5.8 The Tamro Group: Revenue Shares (%) by Country, 2011
Figure 5.9 The PHOENIX Group Revenue Forecast ($bn), 2011-2022
Figure 5.10 Alfresa Holdings Revenue Forecast ($bn), 2011-2022
Figure 5.11 Celesio Wholesale Revenue Shares (%) by Country, 2011
Figure 5.12 Celesio Revenue Forecast ($bn), 2011-2022
Figure 5.13 Alliance Boots Wholesale Revenues ($bn) by Country, 2011
Figure 5.14 Alliance Boots Revenue Forecast ($bn), 2011-2022
Figure 5.15 Suzuken Revenue Forecast ($bn), 2011-2022
Figure 5.16 Medipal Revenue Forecast ($bn), 2011-2022
Figure 6.1 Comparison of the Wholesaler and Direct-to-Pharmacy Routes, 2012
Figure 7.1 Anti-Counterfeiting Strategies in the US and Europe, 2012
Companies Listed AAH PharmaceuticalsAB Acquisitions Ltd
Acofarma (Asociación Cooperativas Farmacéuticas)
Admenta Italia
Alfresa Holdings Corp
Alfresa Medical Service Corp
Alfresa Nikken Sangyo
Alliance Boots
Alliance Healthcare
Alliance Santé
Alliance UniChem
Amedis-UE AG
AmerisourceBergen
Anderson Packaging
Ando Co.
Andreae-Noris Zahn (ANZAG)
Apokjeden
Australian Pharmaceutical Industries
Astellas Pharma
Astis Co
AstraZeneca
Athos Farma
Atol Co
Bayer
Bergen Brunswig
Brecon Pharmaceuticals
Bristol-Myers Squibb
British Association of Pharmaceutical Wholesalers (BAPW)
Brocacef Holding
Bundesverband d
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |